Risk factors which could affect the future results and cause actual results to differ materially from those contained in any forward-looking statements are discussed under Item 3. Key Information  D. Risk Factors. Additional risks, not currently known or considered immaterial by the Group, may have the same unfavorable effect and investors may lose all or part of their investment. Forward-looking statements speak only as of the date they are made. Other than required by law, we do not undertake any obligation to update them in light of new information or future developments. Table of Contents ABBREVIATIONS Abbreviations used in the Form 20-F ADR/ADS American Depositary Receipt/American Depositary Share AFEP Association francaise des entreprises privees´(French association of large companies) AMF Autorité des marcheś financiers (the French market regulator) ANDA Abbreviated New Drug Application ECB European Central Bank BLA Biologic License Application BMS Bristol-Myers Squibb CGU Cash generating unit CHC Consumer Health Care CHMP Committee for Medicinal Products for Human Use CNS Central Nervous System COSO Committee of Sponsoring Organizations of the Treadway Commission COVALIS Health risk prevention committee CSR Corporate Social Responsibility CVMP Committee for Medicinal Products for Veterinary Use CVR Contingent Value Right ECHA European Chemicals Agency ECOVAL Internal committee for assessing the environmental risks of our pharmaceutical products EMA European Medicines Agency EMTN Euro Medium Term Note EPA U.S. Environmental Protection Agency EPS Earnings per share EU European Union FCPA U.S. Foreign Corrupt Practices Act FCPE Fonds commun de placement dentreprise (Corporate investment funds) FDA U.S. Food and Drug Administration GAVI Global Alliance for Vaccines and Immunisation GLP-1 Glucagon-like peptide-1 GMP Good Manufacturing Practice GRI Global Reporting Initiative HSE Health, Safety and Environment IASB International Accounting Standards Board IFRS International Financial Reporting Standards ILO International Labor Organisation LEED Leadership in Energy and Environmental Design LSD Lysosomal storage disorder MEDEF Mouvement des entreprises de France (French business confederation) NASDAQ National Association of Securities Dealers Automated Quotations NDA New Drug Application OECD Organisation for Economic Co-operation and Development OTC Over The Counter PaHO Pan American Health Organisation PRAC Pharmacovigilance Risk Assessment Committee R&D Research & Development REACH Registration, Evaluation, Authorization and restriction of Chemicals ROA Return on assets SEC U.S. Securities and Exchange Commission TRIBIO Internal biological risk committee TSR Total Shareholder Return TSU Therapeutic Strategic Unit UNICEF United Nations Childrens Fund USDA United States Department of Agriculture WHO World Health Organization I Table of Contents Table of contents Item 1. Identity of Directors, Senior Management and Advisers 1 Item 2. Offer Statistics and Expected Timetable 1 Item 3. Key Information 1 A. Selected Financial Data 1 B. Capitalization and Indebtedness 3 C. Reasons for Offer and Use of Proceeds 3 D. Risk Factors 4 